The market's lack of concern about the EPS figure may suggest expected faster earnings drop. The company's poor performance last year indicates unresolved challenges, worse than the annualised loss of 4% over the last half decade.
We see shrinking returns as the company reinvests in its business, potentially causing its relatively low return to shareholders over the past five years. For potential multi-baggers, consider other options.
Elevance Health's ROE and investment strategy have led to a strong market performance. Analysts predict its ROE to stabilize around 15% and for its earnings to accelerate in line with recent forecasts.
$RUSAL(00486.HK)$Yes, profits are going to decline as nickel and aluminum prices have declined but still pretty good value if one has the stomach for the geopolitical risk.
$RUSAL(00486.HK)$Really wanted to buy shares a couple of weeks ago with aluminum prices taking off but just couldn't part with other positions I liked. Should have made the move; oh well.
1
報告
Jeff Boydスレ主 :
Better lucky than good. Price collapsing with Ukrainian developments.
$中国アルミ(02600.HK)$$RUSAL(00486.HK)$The non-ferrous metals sector in Hong Kong stocks continued to rise in the afternoon, with Chalco up nearly 9%, Rusal up nearly 8%, and Zijin Mining up nearly 4%
RUSALに関するコメント
https://www.reuters.com/markets/europe/production-costs-soar-rusal-due-russia-ukraine-conflict-2022-08-12/...
まだコメントはありません